Home › Ariad receives nod to resume US sales of leukemia drug
 

Keywords :   


Ariad receives nod to resume US sales of leukemia drug

2013-12-21 12:09:24| Biotech - Topix.net

Seven weeks after Ariad Pharmaceuticals Inc. was forced to halt US sales of its leukemia drug, prompting an outcry from patients and doctors, the Food and Drug Administration issued new safety measures Friday that will allow the Cambridge biotech to resume selling the medicine.

Tags: sales drug resume receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »